Skin News and Research

RSS

L-Fucose slows down and even reverses age-related skin developments

With increasing age the human skin shows a considerable loss of resistance and elasticity. These changes in skin texture, which are one of the main reasons for the appearance of wrinkles, is the age induced loss of skin thickness and the related degradation of elastin fibers within the skin. It has been proven that L-Fucose - a scarce sugar - slows down and even reverses age-related skin developments.

2 Dec 2012

Cedars-Sinai surgeons use evidence-based protocols to reduce post-operative infections

Surgical teams at Cedars-Sinai have reduced surgical site infections by more than 60 percent for patients who undergo colorectal procedures by introducing evidence-based protocols that are easy to follow and relatively low in cost.

1 Dec 2012

Researchers uncover molecular structure of master regulator central to melanoma

With the X-ray vision of DESY's light source DORIS, a research team from Hamburg and Iceland has uncovered the molecular structure of a master regulator central to the most deadly form of skin cancer, melanoma.

1 Dec 2012

Studies demonstrate effectiveness of Nonin's EQUANOX Advance Model 7600 Oximetry System

Nonin Medical, Inc. announced today the publication of two separate studies that demonstrate the clinical efficacy of the company's EQUANOX Model 7600 Cerebral and Somatic Oximetry System in adult and pediatric patients.

30 Nov 2012

Project shows simple steps reduce hospital infections

Seven health care institutions participated in a quality-improvement project advanced by the Joint Commission and the American College of Surgeons to reduce colorectal surgical-site infection rates. During a two and a half year period, those facilities saved more than $3.7 million by avoiding 135 infections.

30 Nov 2012

Primitive human stem cells resistant to human cytomegalovirus

A new study published online in PLOS ONE reveals that primitive human stem cells are resistant to human cytomegalovirus (HCMV), one of the leading prenatal causes of congenital intellectual disability, deafness and deformities worldwide.

30 Nov 2012

Needless fears linked to severity of autism symptoms in children

Most people know when to be afraid and when it's ok to calm down. But new research on autism shows that children with the diagnosis struggle to let go of old, outdated fears. Even more significantly, the Brigham Young University study found that this rigid fearfulness is linked to the severity of classic symptoms of autism, such as repeated movements and resistance to change.

30 Nov 2012

CSL, PharmaJet partner for needle-free delivery of Afluria influenza vaccine

PharmaJet Inc. has entered into a collaboration with CSL Limited to enable Afluria influenza vaccine to be delivered with the PharmaJet Stratis needle-free jet injector, as soon as the 2013-2014 flu season.

30 Nov 2012

Epizyme to present data from DOT1L and EZH2 inhibitor programs at 54th ASH annual meeting

Epizyme, Inc., a biopharmaceutical company leading the creation of personalized therapeutics to treat patients with genetically defined cancers, today announced the presentation of data evaluating the preclinical safety and efficacy of two of the Company's novel, potent and selective small molecule inhibitors. These inhibitors individually target DOT1L and EZH2, members of a class of epigenic enzymes called histone methyltransferases (HMTs).

30 Nov 2012

Ponatinib thwarts T315I gene mutation in chronic myeloid leukemia

A previously invincible mutation in chronic myeloid leukemia (CML) has been thwarted by an investigational drug in a phase I clinical trial reported in the current edition of The New England Journal of Medicine.

29 Nov 2012

SLU study to use various assays for new TB vaccine development

A pilot study at Saint Louis University Center for Vaccine Development could shape the future of tuberculosis vaccine research by developing tests to identify the most promising vaccine candidates to address this global health crisis.

29 Nov 2012

Nasolabial lip reconstruction provides favorable functional, aesthetic outcomes

Lip reconstruction with the musculocutaneous nasolabial flap following lip resection achieves good functional and aesthetic outcomes, research suggests.

29 Nov 2012

Fertility treatment auto-injector: an interview with Lai Chiu Tang, Senior Industrial Designer at Cambridge Consultants

During IVF treatment you will need to take certain drugs. For example, for IVF it will be Follicle Stimulating Hormones (FSH) which are used to stimulate the ovaries to produce a mature egg so that they can be fertilised externally and then put back into the womb.

29 Nov 2012

Tufts University researchers demonstrate silk-based implantable optics

Tufts University School of Engineering researchers have demonstrated silk-based implantable optics that offer significant improvement in tissue imaging while simultaneously enabling photo thermal therapy, administering drugs and monitoring drug delivery. The devices also lend themselves to a variety of other biomedical functions.

29 Nov 2012

NuFACE receives FDA clearance for Trinity Facial Toning Device

NuFACE is thrilled to announce the launch the FDA cleared Trinity Wrinkle Remover, a red light attachment for the NuFACE Trinity Facial Toning Device. The removable attachment is engineered with advanced LEDs to deliver a precise combination of red and infrared light therapy treatments to reduce full face wrinkles.

29 Nov 2012

Chalmers researcher develops world's first implantable robotic arm controlled by thoughts

The world's first implantable robotic arm controlled by thoughts is being developed by Chalmers researcher Max Ortiz Catalan. The first operations on patients will take place this winter.

28 Nov 2012

Microneedle-based measles vaccine can immunize against measles

Measles vaccine given with painless and easy-to-administer microneedle patches can immunize against measles at least as well as vaccine given with conventional hypodermic needles, according to research done by the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC).

28 Nov 2012

Abdominal and visceral fat detrimental to bone strength in obese men

Visceral, or deep belly, obesity is a risk factor for bone loss and decreased bone strength in men, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

28 Nov 2012

FDA grants final approval to Cobrek’s generic Luxiq foam NDA for treatment of scalp psoriasis

Perrigo Company today announced that its partner, Cobrek Pharmaceuticals, Inc., received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for betamethasone valerate foam 0.12%, the generic equivalent of Luxiq Foam.

28 Nov 2012

Topically applied simvastatin enhances wound recovery in diabetic mice

Delayed wound healing is a major complication of diabetes because the physiological changes in tissues and cells impair the wound healing process. This can result in additional disease outcomes such as diabetic foot ulcer, a significant cause of morbidity in the growing population of diabetic patients. A new study has found that topically applied simvastatin accelerates wound healing in diabetic mice, suggesting important implications for humans with diabetes.

28 Nov 2012